← 返回首页
美国 · 交易所与实时行情 · Nasdaq

Zymeworks Authorized To Buy Back Up To $200 Mln Of Shares

来源:Nasdaq · 美国 1 小时前

详细摘要

(RTTNews) - Zymeworks Inc. (ZYME), a biotechnology company, said Monday that its Board has authorized a second share repurchase program of up to $200 million, which is expected to…

在 Nasdaq 阅读全文 登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.nasdaq.com)

推荐阅读